
Lantern Pharma Inc.
NASDAQ:LTRN
3.42 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 7.511 | 21.938 | 37.202 | 51.524 | 19.229 | 1.232 | 0.445 |
Short Term Investments
| 16,501.984 | 19.365 | 17.994 | 19.201 | 0 | 0 | 0 |
Cash and Short Term Investments
| 24,013.063 | 41.303 | 55.196 | 70.725 | 19.229 | 1.232 | 0.445 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | -0.592 | -0.181 | 0 | 0 | 0 |
Other Current Assets
| 1,234.566 | 1.606 | 3.527 | 1.032 | 0.806 | 0.001 | 0 |
Total Current Assets
| 25,247.629 | 43.341 | 58.723 | 72.716 | 20.237 | 1.233 | 0.445 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 287.425 | 0.28 | 0.096 | 0.216 | 0.022 | 0.009 | 0.005 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 36.738 | 0.026 | 0.018 | 0.018 | 0.101 | 0.191 | 0 |
Total Non-Current Assets
| 324.163 | 0.306 | 0.114 | 1.234 | 0.123 | 0.2 | 0.005 |
Total Assets
| 25,571.792 | 43.648 | 58.836 | 73.95 | 20.36 | 1.433 | 0.45 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 0 | 0 | 0.932 | 0.681 | 0.432 | 0.478 | 0.098 |
Short Term Debt
| 0.191 | 0.173 | 0.053 | 0.152 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | -2.745 | -2.174 | 0 | 0 | 0 |
Other Current Liabilities
| 4,330.984 | 2.505 | 1.813 | 1.493 | 0.12 | 0.011 | 0.554 |
Total Current Liabilities
| 4,331.175 | 2.678 | 2.798 | 2.326 | 0.552 | 0.489 | 0.652 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0.053 | 0.061 | 0 | 0.053 | 0.109 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 52.79 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 52.843 | 0.061 | 0.053 | 0.053 | 0.109 | 0 | 0 |
Total Liabilities
| 4,384.018 | 2.74 | 2.798 | 2.379 | 0.661 | 0.489 | 0.652 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0.014 | 0.007 |
Common Stock
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.011 | 0.011 |
Retained Earnings
| -76,025.617 | -55.244 | -39.283 | -25.023 | -12.66 | -6.752 | -4.324 |
Accumulated Other Comprehensive Income/Loss
| 0.154 | -0.107 | -0.371 | -0.093 | -0 | 0 | 0 |
Other Total Stockholders Equity
| 97,213.236 | 96.259 | 95.691 | 96.686 | 32.358 | 7.695 | 4.103 |
Total Shareholders Equity
| 21,187.774 | 40.908 | 56.038 | 71.571 | 19.699 | 0.943 | -0.202 |
Total Equity
| 21,187.774 | 40.908 | 56.038 | 71.571 | 19.699 | 0.943 | -0.202 |
Total Liabilities & Shareholders Equity
| 25,571.792 | 43.648 | 58.836 | 73.95 | 20.36 | 1.433 | 0.45 |